Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer-Reference-Cited by-同舟云学术

Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer

Published:2012-06 Issue:1 Volume:57 Page:46-50
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Milczek T,Klasa-Mazurkiewicz D,Sznurkowski J,Emerich J

Publisher

Elsevier BV

Subject

General Medicine

Link

http://versita.metapress.com/index/63226382262V5330.pdf

Reference18 articles.

1. Cancer of the ovary;Cannistra;N Engl J Med.,2004

2. Nowotwory złośliwe w Polsce w 2002 roku [Cancer in Poland in 2002].;Wojciechowska,2004

3. Vascular endothelial growth factor serum concentrations in ovarian cancer;Tempfer;Obstet Gynecol.,1998

4. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer;Laudański;Folia Histochem Cytobiol,2011

5. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology;Benedet;Int J Gynaecol Obstet.,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies;Critical Reviews in Oncology/Hematology;2016-06

2. Comparison of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Mitomycin or Carboplatin for Diffuse Malignant Peritoneal Mesothelioma;The American Surgeon;2014-04

3. Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer;World Journal of Obstetrics and Gynecology;2013

4. Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy;Surgical Oncology Clinics of North America;2012-10